Home FDA labels 5eb208ba-9798-92ee-e063-6394a90a7f19 Optase openFDA label record# This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.
Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)
Brand name Optase
Generic name GLYCERIN
Manufacturer Scope Health Inc
Product type HUMAN OTC DRUG
SPL set ID f452a2c4-c869-7bf5-e053-2995a90ac1a0
SPL ID 5eb208ba-9798-92ee-e063-6394a90a7f19
Version 7
Effective date 2026-10-25
Source export date 2026-11-13
Source partition 6
Source file https://download.open.fda.gov/drug/label/drug-label-0006-of-0014.json.zip
Source object key raw/openfda/drug-label/2026-11-13/a79c47b73cf1c0b9829667844daa083c5114cf268a1839f963bc5617e9060c4f/drug-label-0006-of-0014.json.zip
Source manifest SHA-256 8f2b6d063d44586cf97cedcdf1bdf9e261cc88632cc6855424b801bb206208d7
Import run 20261116T150851Z
Imported at 2026-11-16 16:20:02 Harmonized routes table Harmonized routes OPHTHALMIC
Harmonized identifier links# Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.
Harmonized identifiers page 1 of 1 · 10 matching rows.
Warnings cross-check# openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
Warnings sections page 1 of 1 · 1 matching rows.
warnings Warning • For external use only. • If solution changes color or becomes cloudy, do not use. Stop use and ask doctor if • You feel eye pain. • Changes in vision occur. • Redness or irritation of the eye lasts. • Condition worsens or lasts more than 72 hours
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.